All News

The new grant was created to stimulate innovative leadership development practices that enhance outcomes for clinicians, patients, and organizations.

Popular brand-name prescription drugs have seen substantial price increases over the past 6 years, a trend that is likely to continue.

Top news of the day from across the health care landscape.

The National Association of Specialty Pharmacy has named Andy Slavitt, former Center for Medicare and Medicaid Services acting administrator, as the second keynote speaker for their seventh annual meeting.

Pharmacy owners should spend time reviewing marketing arrangements with an attorney who is well-versed in the anti-kickback law to avoid potential pitfalls.

Top news of the day from across the health care landscape.

Which oral medication is used to treat warts in children?

Study could lead to advances in HIV vaccine development because functional immunity to HIV is needed from a vaccine.

Pharmacists and interns who prepare HDs or work in areas where these drugs are located are potentially at risk for these adverse health effects. It is important for us to understand the risks and be proactive about protecting ourselves.

Although recent trials for Merck's pembrolizumab injection demonstrated promise for recurrent or metastatic head and neck squamous cell carcinoma, testing for patients with metastatic triple-negative breast cancer did not meet the primary endpoint.

The survey looked into the participants’ confidence of specific approaches, including outcome-related measures, fee-for-service, intermediate outcome, and outcome-related measures.

The CDC has indicated that many recent measles cases reported in the United States in 2018 have been the result of international travel to areas of the world where the virus is active, and individuals who are not vaccinated against the virus.

Valoctocogene roxaparvovec (BioMarin) met pre-specified criteria for Factor VIII activity levels treating severe hemophilia A in a phase 3 clinical trial.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The agency has opened a public docket to solicit feedback on the proposed requirement, which would necessitate certain immediate-release opioid analgesics be made available in fixed-quantity, unite-of-use blister packaging.

As more novel therapies emerge from the pipeline and enter the market, it is crucial for pharmacists to monitor new drug approvals that could be lifechanging for their patients.

Gilteritinib (Xospata, Astellas Pharma) is indicated for adults with relapsed/refractory acute myeloid leukemia with an FMS-like tyrosine kinase 3 mutation.

Gilteritinib (Xospata, Astellas Pharma) is indicated for adults with relapsed/refractory acute myeloid leukemia with an FMS-like tyrosine kinase 3 mutation.

Patients must be counseled about the risk of acute or chronic liver steatosis associated with all prescription and over the counter medications.

Top news of the day from across the health care landscape.

You know what DNA is, but do you really know what leadership is?

A ‘fail-first’ policy by the Centers for Medicare and Medicaid Services could be a nightmare for patients with cancer, according to the Community Oncology Alliance.

The importance of improving the specialty pharmacy experience for patients newly diagnosed with a life-changing disease.

The oral tablets under review by the FDA should be paired with rest, physical therapy and other measures, according to manufacturer Galt Pharmaceuticals.

The online program trains health care professionals in fundamentals of enteral and parenteral nutrition.

Many patients with pancreatic cancer do not receive cancer-directed treatment that may extend survival.

Top news of the day from across the health care landscape.